169 related articles for article (PubMed ID: 38560961)
1. Signaling pathways in uric acid homeostasis and gout: From pathogenesis to therapeutic interventions.
Yang S; Liu H; Fang XM; Yan F; Zhang Y
Int Immunopharmacol; 2024 May; 132():111932. PubMed ID: 38560961
[TBL] [Abstract][Full Text] [Related]
2. Genetic and Epigenetic Regulation of the Innate Immune Response to Gout.
de Lima JD; de Paula AGP; Yuasa BS; de Souza Smanioto CC; da Cruz Silva MC; Dos Santos PI; Prado KB; Winter Boldt AB; Braga TT
Immunol Invest; 2023 Apr; 52(3):364-397. PubMed ID: 36745138
[TBL] [Abstract][Full Text] [Related]
3. Overnutrition-induced gout: An immune response to NLRP3 inflammasome dysregulation by XOD activity increased in quail.
Wu H; Wang Y; Ren Z; Li Y; Huang J; Lin Z; Zhang B
Front Immunol; 2022; 13():1074867. PubMed ID: 36569836
[TBL] [Abstract][Full Text] [Related]
4. Gout-associated monosodium urate crystal-induced necrosis is independent of NLRP3 activity but can be suppressed by combined inhibitors for multiple signaling pathways.
Zhong CS; Zeng B; Qiu JH; Xu LH; Zhong MY; Huang YT; Xu R; Liu SY; Zha QB; Hu B; Ou-Yang DY; He XH
Acta Pharmacol Sin; 2022 May; 43(5):1324-1336. PubMed ID: 34376811
[TBL] [Abstract][Full Text] [Related]
5. Secretion of IL-1β From Monocytes in Gout Is Redox Independent.
Alberts BM; Bruce C; Basnayake K; Ghezzi P; Davies KA; Mullen LM
Front Immunol; 2019; 10():70. PubMed ID: 30761138
[TBL] [Abstract][Full Text] [Related]
6. 4-(2-(4-chlorophenyl)-1-((4-chlorophenyl)amino)ethyl)benzene-1, 3-diol is a potential agent for gout therapy as a dual inhibitor of XOD and NLRP3.
Zhou M; Li S; Song L; Hu Q; Liu W
Phytomedicine; 2018 Mar; 42():9-17. PubMed ID: 29655702
[TBL] [Abstract][Full Text] [Related]
7. Hyperuricemia-induced NLRP3 activation of macrophages contributes to the progression of diabetic nephropathy.
Kim SM; Lee SH; Kim YG; Kim SY; Seo JW; Choi YW; Kim DJ; Jeong KH; Lee TW; Ihm CG; Won KY; Moon JY
Am J Physiol Renal Physiol; 2015 May; 308(9):F993-F1003. PubMed ID: 25651569
[TBL] [Abstract][Full Text] [Related]
8. Uric acid, hyperuricemia and vascular diseases.
Jin M; Yang F; Yang I; Yin Y; Luo JJ; Wang H; Yang XF
Front Biosci (Landmark Ed); 2012 Jan; 17(2):656-69. PubMed ID: 22201767
[TBL] [Abstract][Full Text] [Related]
9. Lower Temperatures Exacerbate NLRP3 Inflammasome Activation by Promoting Monosodium Urate Crystallization, Causing Gout.
Ahn H; Lee G; Lee GS
Cells; 2021 Jul; 10(8):. PubMed ID: 34440688
[TBL] [Abstract][Full Text] [Related]
10. A wild rice-derived peptide R14 ameliorates monosodium urate crystals-induced IL-1β secretion through inhibition of NF-κB signaling and NLRP3 inflammasome activation.
Charoenwutthikun S; Chanjitwiriya K; Roytrakul S; Kunthalert D
PeerJ; 2023; 11():e15295. PubMed ID: 37197585
[TBL] [Abstract][Full Text] [Related]
11. The role of uric acid in inflammasome-mediated kidney injury.
Braga TT; Foresto-Neto O; Camara NOS
Curr Opin Nephrol Hypertens; 2020 Jul; 29(4):423-431. PubMed ID: 32452918
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of Rhizoma smilacis glabrae extracts on potassium oxonate- and monosodium urate-induced hyperuricemia and gout in mice.
Liang G; Nie Y; Chang Y; Zeng S; Liang C; Zheng X; Xiao D; Zhan S; Zheng Q
Phytomedicine; 2019 Jun; 59():152772. PubMed ID: 31005813
[TBL] [Abstract][Full Text] [Related]
13. EPS8 regulates an NLRP3 inflammasome-independent caspase-1 activation pathway in monosodium urate crystal-treated RAW264.7 macrophages.
Chuang JP; Kao CY; Lee JC; Ling P; Maa MC; Leu TH
Biochem Biophys Res Commun; 2020 Sep; 530(3):487-493. PubMed ID: 32595041
[TBL] [Abstract][Full Text] [Related]
14. The NLRP3 inflammasome - interleukin 1 pathway as a therapeutic target in gout.
Szekanecz Z; Szamosi S; Kovács GE; Kocsis E; Benkő S
Arch Biochem Biophys; 2019 Jul; 670():82-93. PubMed ID: 30710503
[TBL] [Abstract][Full Text] [Related]
15. Phytochemicals in traditional Chinese medicine can treat gout by regulating intestinal flora through inactivating NLRP3 and inhibiting XOD activity.
Liu ZQ; Sun X; Liu ZB; Zhang T; Zhang LL; Wu CJ
J Pharm Pharmacol; 2022 Jul; 74(7):919-929. PubMed ID: 35640306
[TBL] [Abstract][Full Text] [Related]
16. Decoy Receptor 3 Inhibits Monosodium Urate-Induced NLRP3 Inflammasome Activation
Pan YG; Huang MT; Sekar P; Huang DY; Lin WW; Hsieh SL
Front Immunol; 2021; 12():638676. PubMed ID: 33746978
[TBL] [Abstract][Full Text] [Related]
17. Management of Gout-associated MSU crystals-induced NLRP3 inflammasome activation by procyanidin B2: targeting IL-1β and Cathepsin B in macrophages.
Qiao CY; Li Y; Shang Y; Jiang M; Liu J; Zhan ZY; Ye H; Lin YC; Jiao JY; Sun RH; Zhang ZH; Piao MH; Wu YL; Nan JX; Lian LH
Inflammopharmacology; 2020 Dec; 28(6):1481-1493. PubMed ID: 33006110
[TBL] [Abstract][Full Text] [Related]
18. Rutin ameliorates gout via reducing XOD activity, inhibiting ROS production and NLRP3 inflammasome activation in quail.
Wu H; Wang Y; Huang J; Li Y; Lin Z; Zhang B
Biomed Pharmacother; 2023 Feb; 158():114175. PubMed ID: 36587556
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory potential of stevia residue extract against uric acid-associated renal injury in mice.
Mehmood A; Althobaiti F; Zhao L; Usman M; Chen X; Alharthi F; Soliman MM; Shah AA; Murtaza MA; Nadeem M; Ranjha MMAN; Wang C
J Food Biochem; 2022 Oct; 46(10):e14286. PubMed ID: 35929489
[TBL] [Abstract][Full Text] [Related]
20. Precipitation of Soluble Uric Acid Is Necessary for
Alberts BM; Barber JS; Sacre SM; Davies KA; Ghezzi P; Mullen LM
J Rheumatol; 2019 Sep; 46(9):1141-1150. PubMed ID: 30824640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
